Product Information
DIMAPHEN DM ELIXIR is a generic product labeled by Major Pharmaceuticals, priced at $0.0750 per ML under NDC 00904646320. Its NADAC has been published 571 times since Oct 28, 2015.
Strength
2; 10; 5 mg/10mL; mg/10mL; mg/10mL
Manufacturer
Major PharmaceuticalsNDC
00904646320
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
9/11/2006
Pharmacological Classes
Price Statistics
The NADAC for DIMAPHEN DM ELIXIR has been published 571 times since Oct 28, 2015, and over the history we have for it it has risen 332.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0750 per ML |
|---|---|
| All-time high | $0.0750 (Sep 30, 2026) |
| All-time low | $0.0129 (Oct 20, 2021) |
| 52-week high | $0.0750 |
| 52-week low | $0.0210 |
| Median price | $0.0168 |
| Average price | $0.0198 |
| Largest weekly change | +38.4% (Apr 22, 2026) |
| Weeks tracked | 571 |
| Tracking since | Oct 28, 2015 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 79% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIMAPHEN DM ELIXIR?
The current National Average Drug Acquisition Cost (NADAC) for DIMAPHEN DM ELIXIR, manufactured by Major Pharmaceuticals, is $0.0750 per ML (NDC 00904646320), effective Sep 30, 2026.
How has the price of DIMAPHEN DM ELIXIR changed over time?
Over the history we have for it, the NADAC for DIMAPHEN DM ELIXIR has risen 332.5%. It has been tracked across 571 weekly CMS publications since Oct 28, 2015.
What are the highest and lowest recorded NADAC prices for DIMAPHEN DM ELIXIR?
Since Oct 28, 2015, the NADAC for DIMAPHEN DM ELIXIR has ranged from a low of $0.0129 (Oct 20, 2021) to a high of $0.0750 (Sep 30, 2026), with a median of $0.0168 per ML.
Are there cheaper alternatives to DIMAPHEN DM ELIXIR?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHILDREN'S COLD-COUGH ELIXIR, is $0.0159 per ML — about 79% below DIMAPHEN DM ELIXIR.
Who manufactures DIMAPHEN DM ELIXIR?
DIMAPHEN DM ELIXIR (NDC 00904646320) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.